Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles-Reference-Cited by-同舟云学术

Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles

Published:2024-01 Issue: Volume:23 Page:
ISSN:1533-0346
Container-title:Technology in Cancer Research & Treatment
language:en
Short-container-title:Technol Cancer Res Treat

Author:

Boussios Stergios¹²³⁴⁵^ORCID,Ovsepian Saak V.⁶⁷

Affiliation:

1. Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, UK

2. Faculty of Medicine, Health, and Social Care, Canterbury Christ Church University, Canterbury, UK

3. School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, Strand, London, UK

4. Kent and Medway Medical School, University of Kent, Canterbury, UK

5. AELIA Organisation, Thessaloniki, Greece

6. Faculty of Engineering and Science, University of Greenwich London, Chatham Maritime, Kent, UK

7. Faculty of Medicine, Tbilisi State University, Tbilisi, Georgia

Abstract

Early diagnosis is crucial for enhancing the survival rate of renal cell cancer patients, and exosomes present potential advantages in this area. Their small size, high mobility, and lipid bilayer structure enable exosomes to cross biological membranes easily, protecting the bioactive cargo within from degradation. Exosomes significantly influence the invasion and metastasis of RCC, and they also contribute to tumor drug resistance and immune evasion.

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/15330338241275403

Reference11 articles.

1. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

2. Renal Cell Cancer – Insights in Drug Resistance Mechanisms

3. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer

4. Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

5. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma